Chen Chuangui, Kidane Biniam, Mitsos Sofoklis, Jiang Hongjing
Department of Minimally Invasive Esophagus Surgery, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Section of Thoracic Surgery, University of Manitoba, Winnipeg, MB, Canada.
J Thorac Dis. 2024 Jan 30;16(1):542-552. doi: 10.21037/jtd-23-1856. Epub 2024 Jan 16.
The main difficulty of minimally invasive Ivor Lewis (IL) procedure for adenocarcinoma of the esophagogastric junction (AEGJ) is the intrathoracic esophagogastric anastomosis (IEA). We aimed to assess the safety and feasibility of the IL procedure with the da Vinci surgical system for treatment of AEGJ with semi-mechanical intrathoracic IEA.
The cohort included 72 patients with AEGJ who received treatment at the Department of Minimally Invasive Esophagus Surgery of the Tianjin Medical University Cancer Institute and Hospital from August 2020 to March 2023. Of these 72 patients, 17 received neoadjuvant chemo-immunotherapy. The robot-assisted minimally invasive IL procedure was performed using a linear stapler for overlap side-to-side intrathoracic anastomosis and the stapler defect was closed with double full-layer continuous sutures by robotic hand-sewn (semi-mechanical) IEA.
Of the 72 AEGJ patients, 2 were converted to exploration, 7 were converted to laparotomy and thoracotomy for circular-stapled intrathoracic anastomosis, and 6 were converted to thoracotomy for circular-stapled anastomosis, which included 2 cases of extensive pleural adhesion and 4 cases of overlap anastomosis failure, whereas 57 underwent the robot-assisted minimally invasive IL procedure with semi-mechanical IEA. Among the 9 patients converted to laparotomy, the laparotomy rate was closely related to the Siewert classification (P<0.005) and preoperative use of neoadjuvant therapy (P<0.05). Among the 57 patients who underwent the robot-assisted minimally invasive IL procedure with semi-mechanical IEA, there were 2 cases of anastomotic leakages (2/57, 3.5%), no case of anastomotic stricture, 5 cases of postoperative pneumonia (5/57, 8.77%), 2 cases of intensive care unit admission (2/57, 3.5%), and 1 case of readmission within 30 days (1/57, 1.75%). None of the patients died within 30 days after surgery.
The robot-assisted minimally invasive IL procedure with semi-mechanical IEA is both safe and feasible for AEGJ. However, caution is advised for patients with Siewert type III AEGJ and those who have already received preoperative neoadjuvant therapy.
微创Ivor Lewis(IL)手术治疗食管胃交界腺癌(AEGJ)的主要难点在于胸段食管胃吻合术(IEA)。我们旨在评估使用达芬奇手术系统进行IL手术并采用半机械性胸段IEA治疗AEGJ的安全性和可行性。
该队列包括2020年8月至2023年3月在天津医科大学肿瘤医院微创食管外科接受治疗的72例AEGJ患者。在这72例患者中,17例接受了新辅助化疗免疫治疗。采用机器人辅助微创IL手术,使用直线缝合器进行胸段侧侧重叠吻合,吻合器缺损采用机器人手工缝合(半机械性)IEA双层全层连续缝合关闭。
72例AEGJ患者中,2例中转开腹探查,7例中转开腹及开胸行圆形吻合器胸段吻合,6例中转开胸行圆形吻合器吻合,其中2例为广泛胸膜粘连,4例为重叠吻合失败,而57例行机器人辅助微创IL手术并采用半机械性IEA。9例中转开腹患者中,开腹率与Siewert分型密切相关(P<0.005)以及术前使用新辅助治疗(P<0.05)。在57例行机器人辅助微创IL手术并采用半机械性IEA的患者中,有2例吻合口漏(2/57,3.5%),无吻合口狭窄病例,5例术后肺炎(5/57,8.77%),2例入住重症监护病房(2/57,3.5%),1例术后30天内再次入院(1/57,1.75%)。术后30天内无患者死亡。
机器人辅助微创IL手术并采用半机械性IEA治疗AEGJ是安全可行的。然而,对于Siewert III型AEGJ患者以及已接受术前新辅助治疗的患者建议谨慎使用。